Crossmark

Human risk assessment of di-isobutyl phthalate through the application of a developed physiologically based pharmacokinetic model of di-isobutyl phthalate and its major metabolite mono-isobutyl phthalate

Crossref DOI link: https://doi.org/10.1007/s00204-021-03057-5

Published Online: 2021-04-27

Published Print: 2021-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jeong, Seung-Hyun

Jang, Ji-Hun

Cho, Hea-Young

Lee, Yong-Bok https://orcid.org/0000-0002-0797-5324
Funding

Funding for this research was provided by:

Ministry of Food and Drug Safety (17162MFDS117)

Ministry of Education (2020R1A6A3A13074075)
License Information

Text and Data Mining valid from 2021-04-27

Version of Record valid from 2021-04-27
More Information

Article History

Received: 7 March 2021

Accepted: 21 April 2021

First Online: 27 April 2021

Declarations

:

: The authors declare that there are no conflicts of interest regarding the publication of this paper.

Document is current

Any future updates will be listed below